• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

AstraZeneca hopes to make clinical trial operations carbon-negative by 2030

cafead

Administrator
Staff member
  • cafead   Sep 06, 2023 at 10:12: AM
via AstraZeneca has big plans to become carbon-negative by 2030, including collecting human samples obtained in clinical trials.

The company is working with its collaborators, including sites and suppliers to ensure the entire chain footprint is compliant with the company’s ambition.

article source